ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

Sen. Specter Vows to “Stay and Fight” For Health, Education, On Subcommittee.

February 11, 2005

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992

Capitol Hill: Advocates Lobby Congress To Close Medicare Loophole For Colonoscopy Coverage

July 18, 2014

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

NCI Staff Finishes Center Program Study, Submits Recommendations

February 25, 1977

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979